Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gerstoft

Showing results (131-140 of 198) with videos related to

Pageof 20
Sort By:
Journal of Internal Medicine|April 1, 1992
Prognosis in glomerulonephritis. III. A longitudinal analysis of changes in serum creatinine and proteinuria during the course of disease: effect of immunosuppressive treatment. Report from Copenhagen Study Group of Renal DiseasesM Brahm, M Brammer, J T Balsløv, et al.
The Journal of Infectious Diseases|June 1, 1997
Decreased short-term production of tumor necrosis factor-alpha and interleukin-1beta in human immunodeficiency virus-seropositive subjectsH Ullum, J Victor, T L Katzenstein, et al.
HIV Clinical Trials|October 9, 2001
The insufficient suppression of viral load by saquinavir hard gel is reversible: a retrospective cohort studyS Jensen-Fangel, O Kirk, A Blaxhult, et al.
Ugeskrift for Laeger|March 6, 1995
[AIDS in Denmark. 1. Opportunistic infections and malignant diseases. Danish Study Group for HIV infection]J D Lundgren, K D Bentsen, C Pedersen, et al.
Scandinavian Journal of Immunology|March 18, 2000
Effects of subcutaneous interleukin-2 therapy on phenotype and function of peripheral blood mononuclear cells in human immunodeficiency virus infected patientsH Aladdin, C S Larsen, B K Møller, et al.
Scandinavian Journal of Immunology|March 17, 2001
Effects of subcutaneous IL-2 therapy on telomere lengths in PBMC in HIV-infected patientsH Aladdin, C S Larsen, P Schjerling, et al.
BMJ (Clinical Research Ed.)|July 15, 1989
Clinical course of primary HIV infection: consequences for subsequent course of infectionC Pedersen, B O Lindhardt, B L Jensen, et al.
Scandinavian Journal of Immunology|January 1, 1987
Stages in LAV/HTLV-III lymphadenitis. II. Correlation with clinical and immunological findingsJ Gerstoft, G Pallesen, L Mathiesen, et al.
Genitourinary Medicine|February 1, 1988
Hepatitis B in symptomless Danish homosexual menL K Munck, C S Petersen, K Bech, et al.
HIV Medicine|August 18, 2009
Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort studyNiels Obel, D K Farkas, G Kronborg, et al.
Pageof 20

Showing results (131-140 of 198) with videos related to

Sort By:
Pageof 20
Journal of Internal Medicine|April 1, 1992
Prognosis in glomerulonephritis. III. A longitudinal analysis of changes in serum creatinine and proteinuria during the course of disease: effect of immunosuppressive treatment. Report from Copenhagen Study Group of Renal DiseasesM Brahm, M Brammer, J T Balsløv, et al.
The Journal of Infectious Diseases|June 1, 1997
Decreased short-term production of tumor necrosis factor-alpha and interleukin-1beta in human immunodeficiency virus-seropositive subjectsH Ullum, J Victor, T L Katzenstein, et al.
HIV Clinical Trials|October 9, 2001
The insufficient suppression of viral load by saquinavir hard gel is reversible: a retrospective cohort studyS Jensen-Fangel, O Kirk, A Blaxhult, et al.
Ugeskrift for Laeger|March 6, 1995
[AIDS in Denmark. 1. Opportunistic infections and malignant diseases. Danish Study Group for HIV infection]J D Lundgren, K D Bentsen, C Pedersen, et al.
Scandinavian Journal of Immunology|March 18, 2000
Effects of subcutaneous interleukin-2 therapy on phenotype and function of peripheral blood mononuclear cells in human immunodeficiency virus infected patientsH Aladdin, C S Larsen, B K Møller, et al.
Scandinavian Journal of Immunology|March 17, 2001
Effects of subcutaneous IL-2 therapy on telomere lengths in PBMC in HIV-infected patientsH Aladdin, C S Larsen, P Schjerling, et al.
BMJ (Clinical Research Ed.)|July 15, 1989
Clinical course of primary HIV infection: consequences for subsequent course of infectionC Pedersen, B O Lindhardt, B L Jensen, et al.
Scandinavian Journal of Immunology|January 1, 1987
Stages in LAV/HTLV-III lymphadenitis. II. Correlation with clinical and immunological findingsJ Gerstoft, G Pallesen, L Mathiesen, et al.
Genitourinary Medicine|February 1, 1988
Hepatitis B in symptomless Danish homosexual menL K Munck, C S Petersen, K Bech, et al.
HIV Medicine|August 18, 2009
Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort studyNiels Obel, D K Farkas, G Kronborg, et al.
Pageof 20